Seeking Alpha

Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she...

Credit Suisse's Catherine Arnold cuts earnings forecasts for Merck (MRK -6.5%) but says she would buy shares on the dip after the company revealed problems in clinical trials with a drug designed to prevent blood clots. Merck has other attractive drugs in its pipeline, she says, and integration of Schering-Plough will help it grow EPS at a pace faster than its peers.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs